TELA Bio (TELA) Interest Coverage Ratio Growth (1y) (2019 - 2026)
TELA Bio (TELA) Interest Coverage Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 16.91% |
| 10 | TELA Bio | 37.05 Mn | 6.63 Mn | 13.94 Mn | 41.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.59% |
| Mar 31, 2026 | 34.43% |
| Dec 31, 2025 | -178.21% |
| Sep 30, 2025 | 9.73% |
| Jun 30, 2025 | 12.94% |
| Mar 31, 2025 | -110.97% |
| Dec 31, 2024 | 31.14% |
| Sep 30, 2024 | 8.70% |
| Jun 30, 2024 | -67.78% |
| Mar 31, 2024 | 59.89% |
| Dec 31, 2023 | -120.37% |
| Sep 30, 2023 | 3.46% |
| Jun 30, 2023 | 52.73% |
| Mar 31, 2023 | -22.12% |
| Dec 31, 2022 | 203.73% |
| Sep 30, 2022 | -349.13% |
| Jun 30, 2022 | -1,009.38% |
| Mar 31, 2022 | -105.32% |
| Dec 31, 2021 | -320.66% |
| Sep 30, 2021 | 40.32% |